 Jonathan Grinstein
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 32 | 2022 | 667 | 10.500 |
Why?
| | Heart Failure | 30 | 2022 | 1091 | 8.200 |
Why?
| | Hemodynamics | 11 | 2022 | 710 | 3.040 |
Why?
| | Echocardiography, Doppler | 7 | 2020 | 197 | 2.100 |
Why?
| | Aortic Valve Insufficiency | 7 | 2021 | 123 | 2.080 |
Why?
| | Heart Ventricles | 9 | 2022 | 790 | 1.780 |
Why?
| | Ventricular Function, Left | 8 | 2022 | 586 | 1.780 |
Why?
| | Thrombosis | 2 | 2021 | 273 | 1.480 |
Why?
| | Pulmonary Wedge Pressure | 6 | 2021 | 109 | 1.360 |
Why?
| | Shock, Cardiogenic | 2 | 2021 | 72 | 1.050 |
Why?
| | Intra-Aortic Balloon Pumping | 4 | 2021 | 70 | 1.030 |
Why?
| | Ventricular Dysfunction, Right | 2 | 2021 | 134 | 0.900 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2020 | 21 | 0.850 |
Why?
| | Thrombocytopenia | 1 | 2021 | 171 | 0.840 |
Why?
| | Heart Transplantation | 4 | 2021 | 660 | 0.820 |
Why?
| | Coronary Artery Disease | 2 | 2016 | 372 | 0.790 |
Why?
| | Aortic Valve | 4 | 2021 | 204 | 0.770 |
Why?
| | Humans | 41 | 2022 | 83405 | 0.760 |
Why?
| | Prosthesis Implantation | 1 | 2020 | 134 | 0.750 |
Why?
| | Palliative Care | 1 | 2020 | 254 | 0.740 |
Why?
| | Tachycardia, Ventricular | 1 | 2020 | 228 | 0.680 |
Why?
| | Stroke Volume | 2 | 2021 | 436 | 0.670 |
Why?
| | Catheter Ablation | 1 | 2020 | 348 | 0.650 |
Why?
| | Hepatitis C, Chronic | 1 | 2017 | 120 | 0.610 |
Why?
| | Vagus Nerve Stimulation | 1 | 2015 | 8 | 0.600 |
Why?
| | Middle Aged | 18 | 2021 | 25591 | 0.590 |
Why?
| | Troponin T | 1 | 2015 | 32 | 0.570 |
Why?
| | Acute Coronary Syndrome | 1 | 2015 | 45 | 0.560 |
Why?
| | Coronary Artery Bypass | 1 | 2016 | 214 | 0.550 |
Why?
| | Cardiac Output | 3 | 2021 | 159 | 0.550 |
Why?
| | Tissue Donors | 1 | 2017 | 435 | 0.540 |
Why?
| | Male | 22 | 2021 | 41889 | 0.540 |
Why?
| | Myocardial Contraction | 1 | 2015 | 247 | 0.530 |
Why?
| | Prognosis | 6 | 2021 | 3705 | 0.530 |
Why?
| | Blood Platelets | 1 | 2012 | 148 | 0.470 |
Why?
| | Intensive Care Units | 1 | 2015 | 371 | 0.460 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2012 | 116 | 0.450 |
Why?
| | Aspirin | 1 | 2012 | 146 | 0.450 |
Why?
| | Hypertension, Pulmonary | 1 | 2015 | 341 | 0.440 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 2016 | 507 | 0.430 |
Why?
| | Predictive Value of Tests | 4 | 2018 | 1756 | 0.420 |
Why?
| | Female | 19 | 2021 | 44776 | 0.410 |
Why?
| | Cardiac Resynchronization Therapy | 2 | 2021 | 76 | 0.390 |
Why?
| | Aged | 10 | 2021 | 18505 | 0.380 |
Why?
| | Liver Transplantation | 1 | 2017 | 1244 | 0.380 |
Why?
| | Retrospective Studies | 9 | 2021 | 7643 | 0.320 |
Why?
| | Adult | 8 | 2021 | 25992 | 0.310 |
Why?
| | Prosthesis Failure | 2 | 2017 | 147 | 0.300 |
Why?
| | Prospective Studies | 6 | 2021 | 4085 | 0.280 |
Why?
| | Quality of Life | 3 | 2021 | 1369 | 0.280 |
Why?
| | Echocardiography | 3 | 2020 | 892 | 0.270 |
Why?
| | Aorta | 2 | 2021 | 298 | 0.250 |
Why?
| | Hydrodynamics | 1 | 2021 | 17 | 0.230 |
Why?
| | Treatment Outcome | 6 | 2020 | 7901 | 0.230 |
Why?
| | Plasmapheresis | 1 | 2021 | 31 | 0.230 |
Why?
| | Epoprostenol | 1 | 2021 | 54 | 0.230 |
Why?
| | Catheterization, Swan-Ganz | 1 | 2021 | 23 | 0.220 |
Why?
| | Postoperative Complications | 3 | 2020 | 2262 | 0.220 |
Why?
| | Torsion, Mechanical | 1 | 2020 | 5 | 0.220 |
Why?
| | Heparin | 1 | 2021 | 185 | 0.210 |
Why?
| | Thoracic Surgical Procedures | 1 | 2020 | 41 | 0.210 |
Why?
| | Counterpulsation | 1 | 2020 | 21 | 0.210 |
Why?
| | Health Literacy | 1 | 2021 | 52 | 0.210 |
Why?
| | Oxygen Consumption | 1 | 2021 | 250 | 0.210 |
Why?
| | Exercise Tolerance | 1 | 2020 | 50 | 0.210 |
Why?
| | Exercise Test | 1 | 2021 | 175 | 0.210 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 76 | 0.200 |
Why?
| | Pulmonary Artery | 1 | 2021 | 298 | 0.190 |
Why?
| | Systole | 1 | 2019 | 142 | 0.190 |
Why?
| | Prosthesis Design | 2 | 2020 | 303 | 0.190 |
Why?
| | Myocardium | 1 | 2022 | 543 | 0.190 |
Why?
| | Risk Assessment | 3 | 2017 | 2284 | 0.180 |
Why?
| | Muscle Contraction | 1 | 2019 | 306 | 0.180 |
Why?
| | Reoperation | 1 | 2020 | 623 | 0.180 |
Why?
| | Anticoagulants | 1 | 2021 | 399 | 0.170 |
Why?
| | Thermodilution | 1 | 2017 | 21 | 0.170 |
Why?
| | Obesity, Morbid | 1 | 2020 | 211 | 0.170 |
Why?
| | Cardiomyopathies | 1 | 2020 | 254 | 0.170 |
Why?
| | Equipment Safety | 1 | 2016 | 32 | 0.160 |
Why?
| | Computer Simulation | 1 | 2021 | 1059 | 0.160 |
Why?
| | Equipment Failure | 1 | 2016 | 123 | 0.150 |
Why?
| | Stroke | 2 | 2020 | 792 | 0.150 |
Why?
| | Atrial Septum | 1 | 2015 | 9 | 0.150 |
Why?
| | Carotid Sinus | 1 | 2015 | 26 | 0.150 |
Why?
| | Baroreflex | 1 | 2015 | 19 | 0.150 |
Why?
| | Clinical Chemistry Tests | 1 | 2015 | 12 | 0.150 |
Why?
| | Equipment and Supplies | 1 | 2015 | 32 | 0.150 |
Why?
| | Blood Flow Velocity | 1 | 2015 | 207 | 0.150 |
Why?
| | Biological Assay | 1 | 2015 | 77 | 0.150 |
Why?
| | Cause of Death | 1 | 2016 | 273 | 0.150 |
Why?
| | Electric Stimulation Therapy | 1 | 2015 | 43 | 0.150 |
Why?
| | Equipment Design | 1 | 2016 | 422 | 0.140 |
Why?
| | Reference Values | 1 | 2016 | 702 | 0.140 |
Why?
| | Endovascular Procedures | 1 | 2017 | 170 | 0.140 |
Why?
| | Observer Variation | 1 | 2016 | 621 | 0.140 |
Why?
| | Follow-Up Studies | 2 | 2020 | 3877 | 0.140 |
Why?
| | Severity of Illness Index | 2 | 2019 | 1778 | 0.130 |
Why?
| | Patient Selection | 2 | 2020 | 698 | 0.130 |
Why?
| | Acute Disease | 1 | 2015 | 862 | 0.130 |
Why?
| | Platelet Function Tests | 1 | 2012 | 10 | 0.120 |
Why?
| | Platelet Aggregation | 1 | 2012 | 43 | 0.120 |
Why?
| | Treatment Failure | 1 | 2012 | 303 | 0.110 |
Why?
| | Survival Rate | 1 | 2016 | 1919 | 0.110 |
Why?
| | Drug Resistance | 1 | 2012 | 266 | 0.110 |
Why?
| | Reconstructive Surgical Procedures | 1 | 2015 | 272 | 0.110 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 1026 | 0.110 |
Why?
| | Cohort Studies | 1 | 2016 | 2710 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2674 | 0.090 |
Why?
| | alpha-Defensins | 1 | 2007 | 2 | 0.090 |
Why?
| | Risk Factors | 2 | 2020 | 5416 | 0.080 |
Why?
| | Respiratory Mucosa | 1 | 2007 | 89 | 0.080 |
Why?
| | Immunity | 1 | 2007 | 115 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2007 | 397 | 0.070 |
Why?
| | United States | 3 | 2020 | 6313 | 0.060 |
Why?
| | Ventricular Pressure | 1 | 2021 | 30 | 0.060 |
Why?
| | Axillary Artery | 1 | 2020 | 13 | 0.050 |
Why?
| | Trauma Severity Indices | 1 | 2020 | 39 | 0.050 |
Why?
| | Lung | 1 | 2007 | 1061 | 0.050 |
Why?
| | Time Factors | 2 | 2020 | 5496 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2021 | 414 | 0.050 |
Why?
| | Materials Testing | 1 | 2019 | 101 | 0.050 |
Why?
| | Hospitals | 1 | 2021 | 203 | 0.050 |
Why?
| | Hospital Mortality | 1 | 2021 | 323 | 0.050 |
Why?
| | Recovery of Function | 1 | 2020 | 265 | 0.050 |
Why?
| | Motivation | 1 | 2021 | 260 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2020 | 870 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2020 | 759 | 0.040 |
Why?
| | Patient Readmission | 1 | 2020 | 276 | 0.040 |
Why?
| | Incidence | 1 | 2021 | 1639 | 0.040 |
Why?
| | Disease Progression | 1 | 2020 | 1472 | 0.040 |
Why?
| | Animals | 1 | 2015 | 26981 | 0.040 |
Why?
| | Child, Preschool | 1 | 2020 | 3758 | 0.030 |
Why?
| | I-kappa B Proteins | 1 | 2007 | 55 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2007 | 84 | 0.020 |
Why?
| | Antigens, Surface | 1 | 2007 | 134 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2007 | 286 | 0.020 |
Why?
| | Anti-Infective Agents | 1 | 2007 | 106 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2007 | 427 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2007 | 461 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2007 | 369 | 0.020 |
Why?
| | NF-kappa B | 1 | 2007 | 429 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2007 | 627 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2007 | 2100 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2007 | 2969 | 0.010 |
Why?
|
|
Grinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|